April 20, 2015 |
In 1962, President John F. Kennedy committed the nation to landing a man on the moon by decade's end. In July 1969, it was mission accomplished. A half-century later, invoking Kennedy's challenge, scientists at the University of Texas MD Anderson Cancer Center announced they, too, were shooting for the moon. They launched the Cancer Moonshots Program, with the aim of reducing cancer deaths within five to 10 years. "It's a very goal-oriented effort that seems to impact one thing - and that is cancer mortality," Dr. Ronald DePinho, president of MD Anderson, said Saturday at the annual meeting convened by the Philadelphia-based American Association for Cancer Research (AACR)
March 1, 2015 |
Susan Funck got the horrible news on her 47th birthday - Aug. 27, 2012. Her 13-year-old daughter, Hannah Duffy, had a brain tumor. A biopsy later confirmed that the tumor was malignant. It would be fatal. Funck swore from the beginning that she would tell Hannah the whole truth about her diagnosis. Over the next year, Hannah confronted her mortality, sometimes tearfully. She also scored a winning soccer goal in double overtime two weeks after her biopsy. She laughed and celebrated.
January 1, 2015 |
Dow Chemical Co. has quietly settled lawsuits brought by the estates of two chemists who died of brain cancer after working at the former Rohm & Haas Co. research labs in Montgomery County. The company, which purchased Rohm & Haas in 2009, agreed to pay a total of $950,000 - $475,000 in each case, according to records filed in Common Pleas Court in Philadelphia. The settlements bring to a close nearly a decade of litigation, during which plaintiffs' attorneys alleged that Rohm & Haas did not provide lab employees with sufficient protection against toxic chemicals and did not adequately warn them about the rising number of brain cancers.
March 6, 2013
1Colorectal cancer (cancer of the colon and rectum) is the second-leading cancer killer in the United States. 2Colon cancer is an equal opportunity disease, affecting men and women of all racial and ethnic groups and socio-economic backgrounds. 3Colon cancer is most often found in people older than 50, but some people may get the disease at a younger age, especially those with genetic predispositions. 4About 60 percent of colorectal cancer deaths could be prevented with regular screenings.
January 29, 2013 |
Charles Yeo could hardly have been mistaken for a preacher, not with the white lab coat. But as the surgeon mingled among the crowd in a ground floor auditorium at Thomas Jefferson University Hospital, one could see why he referred to the mid-November gathering as "almost a religious experience. " It was the fifth annual Pancreatic Cancer symposium, a chance for survivors and those recently diagnosed to learn about the latest advances and - not least - to give each other moral support.
October 26, 2012 |
NEW YORK - Aspirin, one of the world's oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that's thought to play a role in the disease. Among patients with the mutations, those who regularly took aspirin lived longer than those who didn't, a major study found. Five years after their cancers were diagnosed, 97 percent of the aspirin users were still alive versus 74 percent of those not taking the drug. Aspirin seemed to make no difference in patients who did not have the mutations.
October 18, 2012 |
But for the touch of his wife, Mike Campbell might not have found the lump lurking under his left pectoral muscle until it was too late. For Harvey I. Singer, it took the shooting pain from an old friend's bear hug to finally persuade him to ask his doctor about the change in his left breast. Neither Campbell nor Singer was prepared for the news that his doctor eventually delivered. Even today, most men would be shocked by a similar diagnosis: Campbell and Singer had breast cancer.
December 2, 2010
WITH WORRIES about the economy and stress over the Thanksgiving holiday, you may have forgotten that Nov. 18 was the Great American Smoke Out. This annual event encourages Americans who smoke and or use tobacco products to quit for a single day, with the hope that they will eventually quit for good. Quitting for good is not only the healthiest thing to do, but the most intelligent, too. During the recent holiday, I had the displeasure of reminding a relative of the oh-so-obvious facts about the dangers of cigarette smoking.
October 21, 2010 |
Pfizer Inc.'s hormones, once used by millions of women to ease menopause symptoms, almost doubled the death risk from breast cancer, a U.S. study found. The findings from the U.S.-funded Women's Health Initiative are the first to tie Pfizer's hormone replacement therapy Prempro, already linked to higher rates of breast cancer and heart disease, to increased mortality from tumors. Pfizer, the world's largest drugmaker, on Tuesday won its sixth of 13 jury cases over Prempro's health risks an hour before the research was reported by the Journal of the American Medical Association.
December 8, 2009
THERE are two glaring problems with the Senate health bill. First, it takes $464 billion out of Medicare over 10 years, of which $120 billion comes out of Medicare Advantage, unless you live in New York, Oregon or Florida, exempted cuts through a special deal made before the bill went to the floor. These cuts can't be good for Medicare, which is already becoming insolvent. Those with Medicare Advantage will be forced to buy a Medigap policy to replace the coverage they now have.